NSRGY

Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer

September 3, 2023 · Breaking News

By Adria Calatayud Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer. The Swiss consumer-goods company said Monday that it will receive…

Nestle lifts guidances, confirms plan to buy back $21 billion shares over 2022-24

November 28, 2022 · Breaking News

Nestle SA has lifted its full-year organic sales-growth guidance and outlined targets for 2025 ahead of its investor seminar on Tuesday. The Swiss packaged-foods giant NSRGY, +0.11% NESN,…